Mumbai

Sensex Closes At 19,696.9 After Surging 434 Pts

Sensex Closes At 19,696.9 After Surging 434 PtsTaking a signal from worldwide markets, which gained owing to declining crude oil rates, the 30-share index BSE Sensex made recovery of 434 points (2.3%) on Wednesday to mark its closure at 19,696.9.

The increase was accompanied by a loss during the five successive trading sessions.

Sensex At 18,231.64; IT, Telecom Down

Sensex At 18,231.64; IT, Telecom DownThe 30-scrip sensitive index (Sensex) of the Bombay Stock Exchange (BSE), remained listless during noon today, though broader markets witnessed heavy buying action.

The Sensex, which belled the day at 18,215.28, gained 25.77 points (0.14%) to trade at 18,231.64 as compared to its last closure at 18,205.87.

Previously, the share index had risen to hit the mark of 18,355.84.

Sensex Pares Early Gains On Profit Booking

Sensex Pares Early Gains On Profit BookingThe 30-share index Sensex lost its early gains on account of profit booking witnessed across select heavyweight scrips.

Realty, bankex and IT stocks were in public interest, whereas consumer durable, oil & gas, healthcare and FMCG topped the losers chart.

At 12.57 p. m., the Sensex was trading 69.01 points up at 17,902.55.

In the meantime, the Nifty gained 20.50 points at 5,372.95.

Elder Pharma to market Japanese co products

Mumbai headquartered Elder Pharmaceuticals announced that the company has inked a pact with Japanese drug maker Daiwa Pharmaceuticals.

According to sources, under the proposed agreement, the company will make and sell some of the products of Daiwa Pharmaceuticals in the country.

The sources also revealed that Daiwa Pharmaceuticals proposes to roll out its new product ‘IMBRAN’, a nutritional supplement for immunity enhancement, in the Indian market.

Syndicate content